Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs
Authors
Keywords
Human Immunodeficiency Virus, Zidovudine, West Nile Virus, Efavirenz, Didanosine
Journal
CNS DRUGS
Volume 28, Issue 2, Pages 131-145
Publisher
Springer Nature
Online
2013-12-20
DOI
10.1007/s40263-013-0132-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events
- (2013) Alicia Gutiérrez-Valencia ANNALS OF INTERNAL MEDICINE
- Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV
- (2013) Salvador Cabrera Figueroa et al. CLINICAL DRUG INVESTIGATION
- Brain injury caused by HIV protease inhibitors: Role of lipodystrophy and insulin resistance
- (2012) Sunita Gupta et al. ANTIVIRAL RESEARCH
- No Association of Abacavir Use With Myocardial Infarction
- (2012) Xiao Ding et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Skeletal Muscle Toxicity Associated With Raltegravir-Based Combination Antiretroviral Therapy in HIV-Infected Adults
- (2012) Frederick J. Lee et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya
- (2012) Christine J. McGrath et al. JOURNAL OF NEUROVIROLOGY
- Incidence of Treatment-Limiting Toxicity with Stavudine-Based Antiretroviral Therapy in Cambodia: A Retrospective Cohort Study
- (2012) Vichet Phan et al. PLoS One
- Severe insomnia related to high concentrations of raltegravir
- (2011) Céline Eiden et al. AIDS
- Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
- (2011) Calvin Cohen et al. AIDS
- Peripheral neuropathy in HIV: prevalence and risk factors
- (2011) Scott R Evans et al. AIDS
- Safety of efavirenz in the first trimester of pregnancy
- (2011) Nathan Ford et al. AIDS
- Risk of cerebrovascular events in persons with and without HIV
- (2011) Line D. Rasmussen et al. AIDS
- Successful efavirenz dose reduction guided by therapeutic drug monitoring
- (2011) Aurélie Fayet Mello et al. ANTIVIRAL THERAPY
- Abacavir Use and Risk of Acute Myocardial Infarction and Cerebrovascular Events in the Highly Active Antiretroviral Therapy Era
- (2011) R. J. Bedimo et al. CLINICAL INFECTIOUS DISEASES
- Long-Term Safety from the Raltegravir Clinical Development Program
- (2011) Hedy Teppler et al. CURRENT HIV RESEARCH
- Protease inhibitor monotherapy and the CNS: peace of mind?
- (2011) I. Perez-Valero et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
- (2011) Jean-Michel Molina et al. LANCET
- Non-Nucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine Inhibit Cytochrome C Oxidase in Mouse Brain Regions
- (2011) Emilio L. Streck et al. NEUROCHEMICAL RESEARCH
- Increasing incidence of ischemic stroke in patients with HIV infection
- (2011) B. Ovbiagele et al. NEUROLOGY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy
- (2011) Mar Pujades-Rodríguez et al. PLoS One
- A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population
- (2010) Mark Nelson et al. AIDS
- A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine
- (2010) Laura Waters et al. AIDS
- Efavirenz Plasma Concentrations and Cytochrome 2B6 Polymorphisms
- (2010) Tristan Lindfelt et al. ANNALS OF PHARMACOTHERAPY
- Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s)
- (2010) David B. Clifford et al. HIV CLINICAL TRIALS
- Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
- (2010) B. M. Best et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- African Mitochondrial DNA Subhaplogroups and Peripheral Neuropathy during Antiretroviral Therapy
- (2010) Jeffrey A. Canter et al. JOURNAL OF INFECTIOUS DISEASES
- Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
- (2010) Rubin Lubomirov et al. JOURNAL OF INFECTIOUS DISEASES
- Neuropsychiatric Complications of Efavirenz Therapy: Suggestions for a New Research Paradigm
- (2010) S. Sutterlin et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Acetyl-l-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy
- (2010) E. Vivoli et al. NEUROSCIENCE
- Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- (2010) Tudor J. C. Phillips et al. PLoS One
- RETINAL PIGMENT EPITHELIOPATHY, MACULAR TELANGIECTASIS, AND INTRARETINAL CRYSTAL DEPOSITS IN HIV-POSITIVE PATIENTS RECEIVING RITONAVIR
- (2010) Richard H Roe et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin
- (2009) Matthijs van Luin et al. AIDS
- Efavirenz Treatment and False‐Positive Results in Benzodiazepine Screening Tests
- (2009) Antje Blank et al. CLINICAL INFECTIOUS DISEASES
- Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection
- (2009) V Valcour et al. HIV MEDICINE
- Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations
- (2009) Matthijs van Luin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- CCR5 Deficiency Is a Risk Factor for Early Clinical Manifestations of West Nile Virus Infection but not for Viral Transmission
- (2009) Jean K. Lim et al. JOURNAL OF INFECTIOUS DISEASES
- Age and height predict neuropathy risk in patients with HIV prescribed stavudine
- (2009) C. L. Cherry et al. NEUROLOGY
- OPHTHALMOPLEGIA AND PTOSIS: MITOCHONDRIAL TOXICITY IN PATIENTS RECEIVING HIV THERAPY
- (2009) G. Pfeffer et al. NEUROLOGY
- Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
- (2009) N. Sacktor et al. NEUROLOGY
- Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy
- (2009) Asha R Kallianpur et al. PHARMACOGENOMICS
- Exacerbation of depression associated with starting raltegravir: a report of four cases
- (2008) Marianne Harris et al. AIDS
- Clinical impact of patient population differences and genomic variation in efavirenz therapy
- (2008) Jennifer King et al. AIDS
- A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy
- (2008) Catherine L. Cherry et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Cytokine Genotype Suggests a Role for Inflammation in Nucleoside Analog-Associated Sensory Neuropathy (NRTI-SN) and Predicts an Individual's NRTI-SN Risk
- (2008) Catherine L. Cherry et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Can We Predict Neuropathy Risk before Stavudine Prescription in a Resource-Limited Setting?
- (2008) Jacquita S. Affandi et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy
- (2008) Ronald J. Ellis et al. ANNALS OF NEUROLOGY
- Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of Intracranial Hemorrhage?
- (2008) Amy C. Justice et al. CLINICAL INFECTIOUS DISEASES
- Noise-induced hearing loss in mice treated with antiretroviral drugs
- (2008) Devrim Bektas et al. HEARING RESEARCH
- Effect of Treatment With Efavirenz on Neuropsychiatric Adverse Events of Interferon in HIV/HCV-Coinfected Patients
- (2008) Carmen Quereda et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Slow Efavirenz Metabolism Genotype Is Common in Botswana
- (2008) Robert Gross et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity
- (2008) Emilio L. Streck et al. METABOLIC BRAIN DISEASE
- Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy
- (2008) Erin R. Scruggs et al. PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started